Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.03 (-2.27%)
Close on Nov 18, 2026Market cap $10.60MP/E –Yield –
Vyome operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Vyome's operating income for the twelve months ending Jun 30, 2026 was -$11.92M. For fiscal 2025 it was -$10.45M. The highest annual figure on record is -$1.01M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.45M | – |
| FY2024 | Dec 31, 2024 | -$1.01M | – |
| FY2023 | Dec 31, 2023 | -$15.38M | – |
| FY2022 | Dec 31, 2022 | -$46.35M | – |
| FY2021 | Dec 31, 2021 | -$57.88M | – |
| FY2020 | Dec 31, 2020 | -$12.46M | – |
| FY2019 | Dec 31, 2019 | -$23.23M | – |
| FY2018 | Dec 31, 2018 | -$36.97M | – |
| FY2017 | Dec 31, 2017 | -$34.39M | – |
| FY2016 | Dec 31, 2016 | -$19.51M | – |
| FY2015 | Dec 31, 2015 | -$14.93M | – |
| FY2014 | Dec 31, 2014 | -$9.84M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$862.57K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.13M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.36M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$324.19K | – |
| Q1 FY2025 | Mar 31, 2025 | -$199.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$256.01K | – |
| Q3 FY2024 | Sep 30, 2024 | -$280.98K | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.05M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.90M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.88M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.98M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.63M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.69M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.30M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.24M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.11M | – |
| Q4 FY2021 | Dec 31, 2021 | -$37.52M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.42M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.69M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.26M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.20M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.17M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.00M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.91M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.98M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.74M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.41M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.10M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.66M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.64M | – |
| Q2 FY2018 | Jun 30, 2018 | -$9.60M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.07M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.92M | – |
| Q3 FY2017 | Sep 30, 2017 | -$9.14M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.64M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.69M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.53M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.45M | – |
See a number that looks wrong?